Brief report on the United States Food and Drug Administration Blood Products Advisory Committee recommendations for management of donors and units testing positive for hepatitis B virus DNA.
OBJECTIVE
This article briefly recounts the 21st July 2005, Blood Products Advisory Committee (BPAC) meeting concerning recommendations for management of donors and units testing positive for hepatitis B virus (HBV) DNA.


METHODS
The author attended the meeting. The United States Food and Drug Administration (FDA) web site was used for meeting materials, and handouts were collected at the meeting to provide narrative information. Two European experts assisted with HBV subject matter.


RESULTS
The proceedings of the advisory committee, the issue briefing materials, and testing algorithms are presented.


CONCLUSIONS
BPAC voted concurrence with the FDA algorithm for Management of Donors and Units Testing Positive for Hepatitis B Virus DNA.
Lucey
C
C
21st Century Health Concepts, Ass., Houston, TX, USA. ctlucey@pol.net
D026683:Advisory Committees; D000465:Algorithms; D001769:Blood / Q000821:virology*; D001782:Blood Donors; D004279:DNA, Viral / Q000097:blood*; D006515:Hepatitis B virus / Q000302:isolation & purification*; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration
D004279:DNA, Viral